pharma stocks: Dharmesh Shah on 2 top stock recommendation from pharma sector
” Definitely, SBI for a long time, has seen a downfall today. But looking at the bigger picture for State Bank, I think there is a long way to go,” …
” Definitely, SBI for a long time, has seen a downfall today. But looking at the bigger picture for State Bank, I think there is a long way to go,” …
“We did pick up post results somewhat and would look to add if it corrects more. Then, during the budget time, I had said that a company which we own …
The April-June quarter started on a soft note for Nifty with a sub 5% growth in profit after tax (PAT). This has led to a 2% earnings downgrade from Nuvama …
FMCG and pharma stocks have rallied by up to 23% over the last month, demonstrating their reputation as defensive bets. In contrast, the Nifty50 index has slipped into the red …
Aurobindo Pharma, part of the pharma space, has rallied more than 100% in FY24 but found some resistance above Rs 1,100 levels in January 2024. The stock underwent price wise …
Trideep Bhattacharya, CIO, Edelweiss MF, says: “It will probably take the next year for that improvement to come through. But the valuations over the next one or two quarters would …